Skip to content

Author

I. M. A. Sandika

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Does Germline BRCA1/2 Status Modify the Effect of Neoadjuvant Pembrolizumab on Pathological Complete Response in Early-Stage Triple-Negative Breast Cancer? A Systematic Review and Meta-analysis of Treatment-Biomarker Interactions

The direction of effect is compatible with greater relative pembrolizumab-associated pCR improvement among carriers, but the evidence does not establish a predictive interaction.

I. M. A. Sandika, Made Oka Sastrawan, Ngurah Gede Boyke Arsa Wibawa · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.